A selective inhibitor of cyclin-dependent kinases 4/6, ribociclib, for the treatment of breast cancer

LI Yan, CUI Ying-jie, LIU Juan-juan, ZHAO Hui, WANG Zhen-zhen, ZHOU Yi, ZHANG Jing
Chinese Journal of New Drugs . 2025, (4): 364 -369 .  DOI: 10.20251/j.cnki.1003-3734.2025.04.006